Activation of Fas Ligand/Receptor System Kills Ovarian Cancer Cell Lines by an Apoptotic Mechanism

Greene, 1984, The epidemiology of ovarian cancer, Semin Oncol, 11, 209

Perez, 1991, Ovarian cancer biology, Semin Oncol, 18, 186

Scully, 1995, Pathology of ovarian cancer precursors, J Cell Biochem Suppl., 23, 208, 10.1002/jcb.240590928

Blaustein, 1982, Tumor markers in inclusion cysts of the ovary, Cancer, 49, 722, 10.1002/1097-0142(19820215)49:4<722::AID-CNCR2820490421>3.0.CO;2-C

Nouwen, 1987, Tumor markers in human ovary and its neoplasms. A comparative immunohistochemical study, Am J Pathol, 126, 230

Bell, 1994, Early de novo ovarian carcinoma, Cancer, 73, 1859, 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L

Cramer, 1983, Determinants of ovarian cancer risk, J Natl Cancer Inst, 71, 717

Watanabe-Fukunaga, 1992, The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen, J Immunol, 148, 1274, 10.4049/jimmunol.148.4.1274

Guo, 1994, Identification of Fas antigen associated with apoptotic cell death in murine ovary, Biochem Biophys Res Commun, 203, 1438, 10.1006/bbrc.1994.2346

Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169, 10.1016/0092-8674(93)90326-L

Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5

Oehm, 1992, Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor super family. Sequence identity with the Fas antigen, J Biol Chem, 267, 10709, 10.1016/S0021-9258(19)50076-X

Nagata, 1994, The Fas death factor, Science, 267, 1449, 10.1126/science.7533326

Gill, 1994, Fas antigen and sphingomyelin–ceramide turnover-mediated signaling: role in life and death of lymphocytes, Immunol Rev, 142, 113, 10.1111/j.1600-065X.1994.tb00885.x

Hannun, 1995, The sphingomyelin cycle and the second messenger function of ceramide, J Biol Chem, 269, 3125, 10.1016/S0021-9258(17)41834-5

Jindal, 1994, Transforming growth factor α localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells, Gynecol Oncol, 53, 17, 10.1006/gyno.1994.1080

Khan, 1997, Steroidogenesis -inducing protein (SIP), isolated from human ovarian follicular fluid, is a potent mitogen for cell lines derived from ovarian surface epithelial carcinomas, Gynecol Oncol, 66, 501, 10.1006/gyno.1997.4782

Telford, 1994, Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry, J Immunol Methods, 172, 1, 10.1016/0022-1759(94)90373-5

Kolesnick, 1991, Sphingomyelin and derivatives as cellular signals, Prog Lipid Res, 30, 1, 10.1016/0163-7827(91)90005-P

Folch, 1957, A simple method for isolation and purification of total lipids from animal tissues, J Biol Chem, 264, 19076

Becart, 1990, Quantitative analysis of phospholipids by HPLC with a light scattering evaporating detector—application to raw materials for cosmetic use, J High Resol Chromotogr, 10, 126, 10.1002/jhrc.1240130210

Ravandi, 1996, Isolation and identification of glycated aminophospholipids from red blood cells and plasma of diabetic blood, FEBS Lett, 381, 77, 10.1016/0014-5793(96)00064-6

Obeid, 1993, Programmed cell death induced by ceramide, Science, 259, 1769, 10.1126/science.8456305

Obeid, 1995, Ceramide: a stress signal and mediator of growth suppression and apoptosis, J Cell Biochem, 58, 191, 10.1002/jcb.240580208

Bielawska, 1993, Selectivity of ceramide-mediated biology, J Biol Chem, 268, 26226, 10.1016/S0021-9258(19)74304-X

Hakuno, 1996, Fas/Apo-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicular atresia, Endocrinology, 137, 1938, 10.1210/endo.137.5.8612534

Qurirk, 1995, Fas antigen-mediated apoptosis in human granulosa/luteal cells, Biol Reprod, 52, 279, 10.1095/biolreprod52.2.279

Foghi, A, Dorrington, J, Transforming Growth Factor α (TGFα) plus β (TGFβ) Induces Apoptosis through Sphingomyelin—Ceramide Cycle, The Clinical Research Society of Toronto, Toronto, Ontario, March 1995, 24

Kolesnick, 1994, The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation, Biochem Cell Biol, 72, 471, 10.1139/o94-063

Witty, 1996, Induction of apoptotic cell death in hen granulosa cells by ceramide, Endocrinology, 137, 5269, 10.1210/endo.137.12.8940345

Foghi, A, Ravandi, A, Teerds, K, J, van der Donk, H, Kuksis, A, Dorrington, J, Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway

Traulth, 1989, Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science, 245, 301, 10.1126/science.2787530

Oishi, 1994, Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines, Arch Dermatol Res, 286, 396, 10.1007/BF00371800

Westendorf, 1995, Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines, Blood, 85, 3566, 10.1182/blood.V85.12.3566.bloodjournal85123566

Takeuchi, 1996, Modulation of growth and apoptosis response in PC-3 and LNCAP prostate cancer cell lines by Fas, Int J Cancer, 67, 709, 10.1002/(SICI)1097-0215(19960904)67:5<709::AID-IJC20>3.0.CO;2-Z